1. Home
  2. CLIK vs LYRA Comparison

CLIK vs LYRA Comparison

Compare CLIK & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLIK
  • LYRA
  • Stock Information
  • Founded
  • CLIK 2017
  • LYRA 2005
  • Country
  • CLIK Hong Kong
  • LYRA United States
  • Employees
  • CLIK N/A
  • LYRA 30
  • Industry
  • CLIK
  • LYRA Medical/Dental Instruments
  • Sector
  • CLIK
  • LYRA Health Care
  • Exchange
  • CLIK NYSE
  • LYRA Nasdaq
  • Market Cap
  • CLIK 16.9M
  • LYRA 15.0M
  • IPO Year
  • CLIK 2024
  • LYRA 2020
  • Fundamental
  • Price
  • CLIK $0.45
  • LYRA $10.65
  • Analyst Decision
  • CLIK
  • LYRA Buy
  • Analyst Count
  • CLIK 0
  • LYRA 2
  • Target Price
  • CLIK N/A
  • LYRA $16.00
  • AVG Volume (30 Days)
  • CLIK 806.2K
  • LYRA 1.9M
  • Earning Date
  • CLIK 02-14-2025
  • LYRA 08-13-2025
  • Dividend Yield
  • CLIK N/A
  • LYRA N/A
  • EPS Growth
  • CLIK N/A
  • LYRA N/A
  • EPS
  • CLIK 0.07
  • LYRA N/A
  • Revenue
  • CLIK $6,051,074.00
  • LYRA $1,185,000.00
  • Revenue This Year
  • CLIK N/A
  • LYRA N/A
  • Revenue Next Year
  • CLIK N/A
  • LYRA $1,286.17
  • P/E Ratio
  • CLIK $6.73
  • LYRA N/A
  • Revenue Growth
  • CLIK 36.12
  • LYRA N/A
  • 52 Week Low
  • CLIK $0.16
  • LYRA $3.81
  • 52 Week High
  • CLIK $4.39
  • LYRA $37.50
  • Technical
  • Relative Strength Index (RSI)
  • CLIK N/A
  • LYRA 48.18
  • Support Level
  • CLIK N/A
  • LYRA $9.81
  • Resistance Level
  • CLIK N/A
  • LYRA $27.42
  • Average True Range (ATR)
  • CLIK 0.00
  • LYRA 5.15
  • MACD
  • CLIK 0.00
  • LYRA -1.04
  • Stochastic Oscillator
  • CLIK 0.00
  • LYRA 7.52

About CLIK CLICK HOLDINGS LIMITED

Click Holdings Ltd is a human resources solutions provider, specializing in offering comprehensive human resources solutions. It is focused on talent sourcing and the provision of temporary and permanent personnel to customers and also in placing professional accountants and company secretaries, registered nurses and healthcare workers as well as other blue-collar workers, for direct hire and contract staffing roles. The Company operates in three segments, 1) professional solution services, 2) nursing solution services and 3) logistic and other solution services. Maximum revenue is generated from Professional solution services and Hong Kong.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: